No Products in the Cart
Semaglutide's mechanism of action involves mimicking a natural hormone in the body called GLP-1 which:
Semaglutide is used for weight loss, to lower blood sugar levels in type 2 diabetes, and to reduce the risk of major cardiovascular events and chronic kidney disease in certain adult patients.
Semaglutide is a GLP-1 agonist that works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released.
Semaglutide brand names are Ozempic, Rybelus, and Wegovy , which are made by Novo Nordisk, and are FDA-approved for different conditions. Semaglutide FDA approval was first granted on December 5, 2017, for the brand Ozempic.
By clicking the button you agree to the Privacy Policy and Terms and Conditions